Close Menu

NEW YORK – OraSure Technologies reported after the close of the market on Wednesday that its third quarter revenues fell 22 percent year over year as overall product revenues declined 19 percent.

The firm also announced it will acquire Diversigen, a Houston-based microbiome and metagenomics consulting, sequencing, and data analysis service provider, for a cash purchase price of $12.0 million and the potential for an additional earn-out payment tied to revenue performance.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.